Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03849443 · ClinicalTrials.gov registry record · Early Phase 1
Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery
A Early Phase 1 study of Open Posterior Thoracolumbar Spinal Fusion Procedure, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 604
- Enrollment target
- 1
- Study location
NCT03849443: Recruiting Early Phase 1 study of Open Posterior Thoracolumbar Spinal Fusion Procedure, sponsored by Rush University Medical Center.
NCT03849443 is a Early Phase 1 study of Open Posterior Thoracolumbar Spinal Fusion Procedure that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 604 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (1040% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03849443, a Early Phase 1 study of Open Posterior Thoracolumbar Spinal Fusion Procedure, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 604 participants
- Enrollment target
- 1
- Study location
Study Summary
As tranexamic acid (TXA) becomes more prevalent, all patients are receiving the same dose and method of delivery regardless of their pre-operative risk of transfusion. Therefore, the aim of the study is to determine whether or not repeated dosing of oral or different method of delivery like intravenous (IV) TXA reduces the postoperative reduction in hemoglobin, hematocrit, number of transfusions, and postoperative blood loss following open spine surgery. The regimen that utilizes multiple doses of oral TXA will significantly minimize post-operative blood loss and transfusion requirements compared to the use of a single dose regimen. Furthermore, oral TXA will be as efficacious as intravenous delivery of TXA.
Conditions Studied
Interventions
- DRUG Tranexamic Acid Injectable Product (1000 mg intravenous bolus)
- DRUG Vitamin C 250 MG Oral Tablet
- DRUG Tranexamic Acid 650Mg Tablet
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 604 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2027-01-01 |
| Phase | Early Phase 1 |
What NCT03849443 shows while recruiting
NCT03849443 is an interventional study that assigns participants to a tested intervention. The registered 604 participants enrollment target is mid-sized for trials with a published cap, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (1040% higher).
The record links to 1 condition, with Open Posterior Thoracolumbar Spinal Fusion Procedure appearing as the primary indexed condition, and to 3 interventions - of which Tranexamic Acid Injectable Product (1000 mg intravenous bolus) is the first listed.
NCT03849443 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03849443 about?
NCT03849443 is a clinical study titled "Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery". As tranexamic acid (TXA) becomes more prevalent, all patients are receiving the same dose and method of delivery regardless of their pre-operative risk of transfusion. Therefore, the aim of the study is to determine whether or not repeated dosing of oral or different method of delivery like intraven...
What is the current status of trial NCT03849443?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 604 participants. The study started on 2019-08-26. Estimated completion is 2027-01-01.
What conditions does trial NCT03849443 study?
This clinical trial studies the following conditions: Open Posterior Thoracolumbar Spinal Fusion Procedure.
What interventions are being tested in trial NCT03849443?
The interventions under investigation include: Tranexamic Acid Injectable Product (1000 mg intravenous bolus) (DRUG), Vitamin C 250 MG Oral Tablet (DRUG), Tranexamic Acid 650Mg Tablet (DRUG).
Who is sponsoring clinical trial NCT03849443?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03849443 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03849443's enrollment target sits among peer trials
604 17th of 2000 higher than 1,984 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05238922 · 604 participants · Phase 1
Study of INCB123667 in Subjects With Advanced Solid Tumors
- NCT06040541 · 604 participants · Phase 1
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- NCT02342444 · 606 participants · Phase 4
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
- NCT02064673 · 608 participants · Phase 3
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI